Trading Symbol: NUVM Exact title and class of securities outstanding: Common Stock CUSIP: 67071X100 Par or Stated Value: $0.00001 par value per share Total shares authorized: 120,000,000 as of: September 30, 2020 Total shares outstanding: 97,956,639 as of: September 30, 2020 Number of shares in the Public Float: 58,321,565 as of: September 30, 2020 Total number of shareholders of record: 209 as of: September 30, 2020
A new improved formula of 5 varieties of the powder mix product line has been developed, taste tested and tested for extended shelf life. These products have been developed with the assistance of dieticians, Doctor John St. Cyr, and other resource groups including professional product
OTC Markets Group Inc. OTC Pink Basic Disclosure Guidelines (v2.0 February 2019) Page 6 of 9 development specialists. Doctor St. Cyr has been retained as a consultant going forward and will endorse the reformulated products when they are introduced to the market. These new products incorporate a unique combination of compounds in the right amounts to provide a level of antioxidants designed to help neutralize free radicals, thus maintaining healthy functioning body cells and enhancing immune health and cardiovascular health, muscle and bone strength and mental acuity. There is also a prebiotic included to increase beneficial bacteria in the gut, indigenous to the digestive system. The new NuVim has compounds that promote healthy skin and a much shorter recovery time when feeling fatigued and run down. All compounds are considered by the FDA as Generally Recognized as Safe (GRAS). The all-natural product line does not contain caffeine, fat, cholesterol, gluten, lactose, or a high caloric level. There are less than 20 calories per serving. The products deliver a good source of fiber, prebiotics for beneficial bacterial growth, vitamins C, E, B12, D3, and L-Citrulline. The reformulated product is excellent for professional and amateur athletes, the weekend warrior and everyday busy consumers who want to live a healthier, more energetic quality of life. In addition to the new product line growth initiative, the Company has evaluated several potential partnerships in the form of joint ventures, technology license agreements, or mergers. Ongoing discussions continue with one potential interested partner. The Company has little short-term debt and approximately $167,126 in long term debt. This is a significant improvement of the balance sheet from 2015 when the debt load was $1.2 million. This task was accomplished without a significant dilution of the shareholders. Total shares outstanding is approximately 96 million. There are 120 million common shares authorized and 65 million preferred authorized. No preferred shares are outstanding. Filings with the Over the Counter Markets have been complete and on schedule for more than the past three years
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.